Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Fananserin is an antagonist of the serotonin (5-HT) receptor subtype 5-HT2 (IC50 = 0.12 nM for the rat receptor).1 It is selective for 5-HT2 over 5-HT1A, 5-HT3, the α1-adrenergic receptor (α1-AR), dopamine D2 receptor (IC50s = 75, 6,600, 4.3, and 390 nM, respectively, for the rat receptors), and histamine H1 receptor (IC50 = 50 nM for the guinea pig receptor). Fananserin is also an antagonist of the dopamine D4 receptor (Ki = 2.93 nM for the human receptor).2 It inhibits the head-twitch response (HTR) induced by mescaline in mice (ED50 = 0.16 mg/kg). Fananserin (2 or 4 mg/kg) increases time in deep non-rapid eye movement (NREM) sleep and decreases time in light NREM sleep in rats.3 It increases the time spent in the open arms of the elevated plus maze in mice when administered at doses of 0.25, 1, or 4 mg/kg.4
WARNING This product is not for human or veterinary use.
1. Pharmacological characterization of RP 62203, a novel 5-
2. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor. Eur. J. Pharmacol. 314(1-2), 229-233 (1996).
3. RP 62203, a 5-
4. Are 5-